TY  - GEN
AU  - Armstrong,A J
AU  - Halabi,S
AU  - Healy,P
AU  - Lee,W R
AU  - Koontz,B F
AU  - Moul,J W
AU  - Mundy,K
AU  - Creel,P
AU  - Wood,S
AU  - Davis,K
AU  - Carducci,M A
AU  - Stein,M
AU  - Hobbs,C
AU  - Reimer,B
AU  - Nguyen,M
AU  - Anand,M
AU  - Bratt,L
AU  - Kim,S
AU  - Tran,P T
AU  - George,D J
TI  - A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy
SN  - 1476-5608
PY  - 2016///1027
KW  - Adult
KW  - Aged
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Humans
KW  - Indoles
KW  - administration & dosage
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Grading
KW  - Neoplasm Recurrence, Local
KW  - drug therapy
KW  - Prednisone
KW  - Prostate-Specific Antigen
KW  - metabolism
KW  - Prostatectomy
KW  - Prostatic Neoplasms
KW  - Pyrroles
KW  - Quality of Life
KW  - Salvage Therapy
KW  - Sunitinib
KW  - Taxoids
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/pcan.2015.59
ER  -